2013 Fall Clinical Lipid Update Highlights
Keynote: HDL ReviewFaculty: Alan T. Remaley, MD, PhD
Alan T. Remaley, MD, PhD presented HDL Review: Translating new findings on LCAT into novel therapies. He explains the biology of HDL and LCAT, and he discusses Phase I Clinical trial of rLCAT and single patient IND treatment.
Is Raising HDL Dead or Not?Faculty: John R. Guyton, M.D.
John R. Guyton, M.D. presented Niacin's Triple Paradox and Thoughts on HDL. Dr. Guyton discusses the three paradox of Niacin.
Genetics of Familial HypercholesterolemiaFaculty: Marina Cuchel, MD, PhD
Marina Cuchel, MD, PhD presented Genetics of Familial Hypercholesterolemia. Dr. Cuchel discuss FH (Familial Hypercholesterolemia), the underlying genetic defects that cause FH, and how the molecular basis of FH affects lipid lowering treatment.
Genetic Testing – Where are we? Nuts & Bolts of TestingFaculty: Josh W. Knowles, MD, PhD
Josh W. Knowles, MD, PhD presented Nuts and Bolts of Genetic Testing for Familial Hypercholesterolemia. Dr. Knowles discusses the importance of genetic testing, the cost effectiveness of cascade screening, and what to expect when ordering genetic testing for patients
Cardiometabolic Consequences of Sitting TimeFaculty: Marc Hamilton, PhD
Marc Hamilton, PhD presented Cardiometabolic Consequences of Sitting Time: Inactivity Physiology. Dr. Hamilton explains inactivity physiology and Low-Intensity Physical Activity, LIPA.